Insider · CIK 0001626003
Yuval Cohen
Files at CRBP (Corbus Pharmaceuticals Holdings, Inc.). First filing Feb 18, 2025, latest Feb 18, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CRBP: Corbus Pharmaceuticals Holdings, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | Corbus Pharmaceuticals Holdings, Inc. | $108k 13,871 shares | -7% | +54% from low-61% from high | |
| 27Weak | Corbus Pharmaceuticals Holdings, Inc. | $471k 27,633 shares | -18% | +243% from low-13% from high | |
| 20Weak | Corbus Pharmaceuticals Holdings, Inc. | $62k 7,134 shares | -5% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 13, 2026 | CRBP Corbus Pharmaceuticals Holdings, Inc. | SOpen-market sale Common Stock, par value $0.0001 per share10b5-1 | -13,871 | $7.78 | $108k | 174,316 | Feb 18, 2026 |
| Jan 14, 2026 | CRBP Corbus Pharmaceuticals Holdings, Inc. | AGrant or award Common Stock, par value $0.0001 per share | +50,000 | $0.00 | $0 | 188,187 | Jan 16, 2026 |
| Jan 14, 2026 | CRBP Corbus Pharmaceuticals Holdings, Inc. | AGrant or award Stock options (right to buy)derivative | +150,000 | $0.00 | $0 | 150,000 | Jan 16, 2026 |
| Oct 24, 2025 | CRBP Corbus Pharmaceuticals Holdings, Inc. | MOption exercise Common Stock, par value $0.0001 per share10b5-1 | +18,660 | $4.26 | $79k | 156,847 | Oct 27, 2025 |
| Oct 24, 2025 | CRBP Corbus Pharmaceuticals Holdings, Inc. | SOpen-market sale Common Stock, par value $0.0001 per share10b5-1 | -18,660 | $17.01 | $317k | 138,187 | Oct 27, 2025 |
| Oct 27, 2025 | CRBP Corbus Pharmaceuticals Holdings, Inc. | MOption exercise Common Stock, par value $0.0001 per share10b5-1 | +8,973 | $4.26 | $38k | 147,160 | Oct 27, 2025 |
| Oct 27, 2025 | CRBP Corbus Pharmaceuticals Holdings, Inc. | SOpen-market sale Common Stock, par value $0.0001 per share10b5-1 | -8,973 | $17.14 | $154k | 138,187 | Oct 27, 2025 |
| Oct 24, 2025 | CRBP Corbus Pharmaceuticals Holdings, Inc. | MOption exercise Stock options (right to buy)derivative10b5-1 | -18,660 | $0.00 | $0 | 31,079 | Oct 27, 2025 |
| Oct 27, 2025 | CRBP Corbus Pharmaceuticals Holdings, Inc. | MOption exercise Stock options (right to buy)derivative10b5-1 | -8,973 | $0.00 | $0 | 22,106 | Oct 27, 2025 |
| Feb 14, 2025 | CRBP Corbus Pharmaceuticals Holdings, Inc. | SOpen-market sale Common Stock, par value $0.0001 per share10b5-1 | -7,134 | $8.76 | $62k | 138,187 | Feb 18, 2025 |
| Jan 31, 2025 | CRBP Corbus Pharmaceuticals Holdings, Inc. | AGrant or award Common Stock, par value $0.0001 per share | +68,100 | $0.00 | $0 | 145,321 | Feb 4, 2025 |
| Jan 31, 2025 | CRBP Corbus Pharmaceuticals Holdings, Inc. | AGrant or award Stock options (right to buy)derivative | +228,800 | $0.00 | $0 | 228,800 | Feb 4, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.